About Kingfisher Biotech
Founded in 2001, Kingfisher Biotech develops research reagents for animal model and veterinary science, with a particular focus on immunology, inflammation and host-pathogen interactions. The company supports basic and translational research by producing species-specific proteins, antibodies and immunoassays that enable investigators to study immune signalling pathways across a broad range of laboratory and agricultural species. Its expertise centres on cytokines, chemokines, interferons and growth factors, providing tools for analysing immune responses, disease mechanisms, vaccine studies and comparative biology in both veterinary and human disease models.
Kingfisher Biotech’s portfolio includes recombinant proteins, monoclonal and polyclonal antibodies, and ELISA kits designed for animal health and animal model research. These reagents support applications such as cytokine quantification, biomarker analysis, cell culture studies, functional immune assays and assay development. The company maintains extensive multi-species coverage, supplying reagents for livestock, companion animal, wildlife and traditional laboratory research models, including bovine, porcine, equine, canine, feline, rabbit, rodent and avian species. Its product range is widely used in veterinary immunology, infectious disease, inflammation, vaccine development and translational research workflows.
Europa Biosite’s subsidiaries distribute for Kingfisher Biotech in Austria, Germany and the United Kingdom.